A business in context

VANI research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-15 · 0001753926-26-001963

  2. 8-K · Current report

    Report date 2026-09-16 · 0001753926-26-001808 · Items 7.01

  3. 8-K · Current report

    Report date 2026-08-17 · 0001753926-26-001536 · Items 7.01,9.01

  4. 8-K · Current report

    Report date 2026-08-13 · 0001753926-26-001482 · Items 2.02,7.01,9.01

  5. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001753926-26-001477

  6. 8-K · Current report

    Report date 2026-08-06 · 0001753926-26-001349 · Items 7.01,9.01

  7. 4 · Ownership change

    Report date 2026-07-28 · 0001753926-26-001286

  8. 4 · Ownership change

    Report date 2026-07-28 · 0001753926-26-001285

  9. 4 · Ownership change

    Report date 2026-07-28 · 0001753926-26-001284

  10. 4 · Ownership change

    Report date 2026-07-28 · 0001753926-26-001283

  11. 4 · Ownership change

    Report date 2026-07-28 · 0001753926-26-001282

  12. 4 · Ownership change

    Report date 2026-07-27 · 0001753926-26-001243

  13. 4 · Ownership change

    Report date 2026-07-15 · 0001753926-26-001192

  14. 8-K · Current report

    Report date 2026-07-15 · 0001753926-26-001190 · Items 7.01,9.01

  15. 8-K · Current report

    Report date 2026-07-01 · 0001753926-26-001144 · Items 1.01,8.01,9.01

  16. 8-K · Current report

    Report date 2026-06-24 · 0001753926-26-001109 · Items 5.02,5.07,8.01,9.01

  17. 8-K · Current report

    Report date 2026-06-04 · 0001753926-26-000974 · Items 7.01,9.01

  18. 8-K · Current report

    Report date 2026-05-13 · 0001753926-26-000854 · Items 2.02,7.01,9.01

  19. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001753926-26-000852

  20. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001753926-26-000750

  21. 8-K · Current report

    Report date 2026-03-26 · 0001753926-26-000550 · Items 2.02,9.01

  22. 10-K · Annual report

    Report date 2025-12-31 · 0001753926-26-000548

  23. 8-K · Current report

    Report date 2026-01-25 · 0001753926-26-000194 · Items 1.01,3.02,7.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001753926-25-001770

  25. 8-K · Current report

    Report date 2025-11-13 · 0001753926-25-001768 · Items 2.02,7.01,9.01

  26. 8-K · Current report

    Report date 2025-10-26 · 0001753926-25-001655 · Items 1.01,3.02,7.01,9.01

  27. 8-K · Current report

    Report date 2025-10-03 · 0001753926-25-001582 · Items 7.01,8.01,9.01

  28. 8-K · Current report

    Report date 2025-09-17 · 0001753926-25-001510 · Items 8.01,9.01

  29. 8-K · Current report

    Report date 2025-09-09 · 0001753926-25-001443 · Items 7.01,9.01

  30. 8-K · Current report

    Report date 2025-09-04 · 0001753926-25-001431 · Items 8.01,9.01

  31. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001753926-25-001330

  32. 8-K · Current report

    Report date 2025-08-11 · 0001753926-25-001328 · Items 1.01,2.02,3.02,7.01,8.01,9.01

  33. 8-K · Current report

    Report date 2025-08-05 · 0001753926-25-001228 · Items 2.02,7.01,8.01,9.01

  34. 8-K · Current report

    Report date 2025-06-24 · 0001753926-25-001005 · Items 5.07

  35. 8-K · Current report

    Report date 2025-06-17 · 0001753926-25-000966 · Items 7.01,9.01

  36. 8-K · Current report

    Report date 2025-06-11 · 0001753926-25-000956 · Items 5.02,7.01,9.01

  37. 8-K · Current report

    Report date 2025-05-29 · 0001753926-25-000898 · Items 8.01,9.01

  38. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001753926-25-000794

  39. 8-K · Current report

    Report date 2025-05-12 · 0001753926-25-000792 · Items 1.01,2.02,3.02,7.01,8.01,9.01

  40. DEF 14A · Proxy statement

    Report date 2025-06-24 · 0001753926-25-000694

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 1 transaction rows1PSale: 0 transaction rows0SGrant / award: 11 transaction rows11AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

12 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-28
2026-07-30
Dwyer DonaldA · Grant / award
Acquired
RSUs
Derivative security
35000.00.0
2026-07-28
2026-07-30
Dwyer DonaldA · Grant / award
Acquired
Common Stock Option
Derivative security
70000.00.0
2026-07-28
2026-07-30
Porter Lisa EllenA · Grant / award
Acquired
Common Stock Option
Derivative security
80000.00.0
2026-07-28
2026-07-30
Porter Lisa EllenA · Grant / award
Acquired
RSUs
Derivative security
40000.00.0
2026-07-28
2026-07-30
Baldor AnthonyA · Grant / award
Acquired
RSUs
Derivative security
37500.00.0
2026-07-28
2026-07-30
Baldor AnthonyA · Grant / award
Acquired
Common Stock Option
Derivative security
75000.00.0
2026-07-28
2026-07-30
Le TrucA · Grant / award
Acquired
RSUs
Derivative security
80000.00.0
2026-07-28
2026-07-30
Le TrucA · Grant / award
Acquired
Common Stock Option
Derivative security
160000.00.0
2026-07-28
2026-07-30
Mendelsohn AdamA · Grant / award
Acquired
RSUs
Derivative security
100000.00.0
2026-07-28
2026-07-30
Mendelsohn AdamA · Grant / award
Acquired
Common Stock Option
Derivative security
200000.00.0
2026-07-27
2026-07-28
BRADBURY DANIELA · Grant / award
Acquired
Non-Qualified Stock Option (right to buy)
Derivative security
7965.01.3
2026-07-15
2026-07-16
Williams GreggP · Purchase
Acquired
Common Stock793650.01.26

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001266806Vivani Medical, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names
  • SECOND SIGHT MEDICAL PRODUCTS INC · former SEC name · 2006-05-02 to 2022-08-18
  • SECOUND SIGHT MEDICAL PRODUCTS INC · former SEC name · 2003-10-10 to 2003-10-10

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0
2019-12-31$3.38M$4.45M
2018-12-31$6.90M$9.25M
2017-12-31$7.96M$10.95M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗